News

Check out market updates

Brickell Biotech closes enrollment for final U.S. clinical trial

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) said it ended enrollment for its pivotal Phase III trial for its flagship […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X